Mehmet A N Sendur Sercan Aksoy Nuriye Yıldırım Özdemir Nurullah Zengin
10.4103/0253-7613.125195
Indian J Pharmacol
2014 Jan-Feb;46(1):125-6.
adverse drug reactions bevacizumab colorectal cancer necrotizing fasciitis
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/24550600/
Adenocarcinoma / drug therapy Antibodies, Monoclonal, Humanized / adverse effects Fasciitis, Necrotizing / chemically induced Liver Neoplasms / secondary Rectal Neoplasms / drug therapy
Adenocarcinoma / drug therapy Antibodies, Monoclonal, Humanized / adverse effects Fasciitis, Necrotizing / chemically induced Liver Neoplasms / secondary Rectal Neoplasms / drug therapy Case Reports Adenocarcinoma / pathology Adenocarcinoma / radiotherapy Antibodies, Monoclonal, Humanized / therapeutic use Bevacizumab Combined Modality Therapy Fatal Outcome Humans Male Middle Aged Rectal Neoplasms / pathology Rectal Neoplasms / radiotherapy Antibodies, Monoclonal, Humanized Bevacizumab
PMC3912798
24550600
Necrotizing fasciitis secondary to bevacizumab treatment for metastatic rectal adenocarcinoma
2014